iwoca Funded £14.5m Of Shareholder Liquidity Before A Possible Sale

iwoca funded approximately £14.5 million of purchases from shareholders through its employee benefit trust before bankers began sounding out a possible sale expected to value the lender above £1 billion.

The company's 2024 accounts split the programme into about £5.4 million provided before year-end and a further £9.1 million afterward. The auditor called the resulting share purchase an approximately £15 million return to shareholders and treated it as a new key audit matter.

The accounts do not identify the sellers. They do not show that founders James Dear or Christoph Rieche received any of the money, and they do not give a seller-by-seller price. What they establish is that company-funded shareholder liquidity occurred before Sky News reported through Channel 103 that Qatalyst Partners was sounding out potential buyers.

The ownership record adds a second complication. Dear and Rieche together held about 25.15% of the last complete filed cap table, while Series D ranked first among iwoca's visible equity classes in a liquidation. That class had grown by 10.85% by June 2026.

For private-market readers, a £1 billion sale headline would not be a payout statement. Some liquidity has already occurred, 135 legal holders appear in the last complete shareholder filing, and the visible share classes do not stand in one equal queue.

One Share Purchase, Funded In Two Stages

iwoca's accounts describe one EBT purchase programme, not two separate £15 million and £9.1 million programmes. The statement of changes in equity records £5.325 million of shares acquired by the EBT at 31 December 2024. The directors' report rounds the pre-year-end gift to £5.4 million and says another £9.1 million was provided afterward.

The auditor's rounded description of approximately £15 million is consistent with that total. Its work included reviewing the transaction documents and testing amounts paid to shareholders against iwoca's bank statements.

That gives the transaction more weight than a generic employee-option administration note. Cash moved from the company into a trust to purchase existing shares. The unresolved part is allocation. Without the EBT seller schedule, no public source establishes which holders sold, how much each received or whether the transaction changed founder ownership.

The last confirmation statement shows Intertrust Employee Benefit Trustee Limited holding 563,937 ordinary and B ordinary shares, or 4.43% of issued capital, on 23 October 2025. That is the trust's filed holding after the purchase period, not proof that every share was acquired in this programme or that the trust is the economic owner in the same sense as an investor.

The Company Was Growing And Profitable

The EBT purchase did not occur inside a shrinking or loss-making group. iwoca's filed 2024 numbers show rapid growth and a £44.1 million total comprehensive gain.

This is the strongest counter-reading of the shareholder purchase. A profitable growth company can use an EBT to create controlled liquidity, support employee ownership and manage a long private-company cap table without preparing for an immediate exit.

The new sale report does not overturn that explanation. The reported process is exploratory. Channel 103's Sky News report says strategic and financial investors were expected to examine offers, while iwoca said it does not comment on strategic or finance plans. Independent coverage also cautioned that the process was early and might produce no transaction.

The large funding facilities belong to a different economic layer. iwoca raises debt and structured funding to support its SME loan book. Our earlier analysis of iwoca's ring-fenced funding issuer showed why a facility headline cannot be treated as unrestricted corporate cash or exit proceeds.

The Named Owner List Extends Far Beyond The Founders

The full confirmation statement dated 23 October 2025 contains 169 current shareholding records across five classes. Aggregating multiple class entries by legal holder produces 135 holders and exactly reconciles to 12,720,075 shares.

The 15 largest legal holders account for 87.31% of that total. The remaining 120 hold 12.69%.

These percentages are issued-share positions, not fully diluted ownership and not current post-June 2026 stakes. The legal-holder names also do not by themselves establish ultimate beneficial ownership.

The list nevertheless changes the founder narrative. Dear held 12.98% and Rieche 12.17%, for 25.15% combined. They were the largest and third-largest legal holders, but they did not own a majority of the issued capital. A sale would therefore distribute value across founders, funds, corporate vehicles, an EBT and many smaller holders, subject to class rights and the actual deal structure.

A disciplined UK Companies House ownership workflow matters here because one holder can appear in several class entries. Reading only one row would understate Dear, Rieche, Prime IV, Redline, Acton, CommerzVentures and several others.

Series D Sits First In The Visible Equity Queue

iwoca's filed capital has four economic levels above B ordinary: Preferred, Series C and Series D, with ordinary shares at the base. The prescribed rights say Preferred ranks ahead of Ordinary, Series C ranks ahead of Preferred, and Series D ranks ahead of Series C in liquidation.

That wording does not put Series D ahead of creditors. It also does not disclose a preference multiple or the cash amount each holder would receive. It establishes the order among the visible equity classes.

The October 2025 statement identifies every holder of the then 777,022 Series D shares.

Augmentum and Prime IV together held 68.96% of the senior visible class at that date. The founder holdings in the statement were ordinary and B ordinary, not Series D.

The class then expanded. A January 2026 return records 56,513 new Series D shares at £23.65 each, implying approximately £1.337 million. By 23 June, the latest statement of capital showed 861,296 Series D shares, 84,274 more than in October and an increase of 10.85%.

The public filings do not provide a post-June holder allocation. They therefore show that the senior layer grew, but not who received the additional shares or what every later share cost.

A Sale Price Still Needs A Distribution Map

The reported £1 billion-plus figure may eventually become an enterprise value, an equity value or nothing at all. Even if a transaction completes, it will not answer the shareholder questions on its own.

The clean conclusion is not that founders cashed out or that preferred investors will capture a specific sum. Neither claim is public.

The supported finding is more useful. Before Qatalyst began sounding out a possible sale, iwoca had already funded about £14.5 million of shareholder purchases. The last complete owner list showed 135 legal holders, with the founders on 25.15% combined. Series D sat first among the visible equity classes and grew by 10.85% before the reported process.

A future buyer may still create substantial value for every layer. The seller schedule, updated holder list and sale waterfall will determine who had already received liquidity and who stands first for the next pound.